| 000 | 01499cam a2200301 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 130302s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2012.Ma.F | ||
| 100 | 0 | _aMayada Elhadi Babiker Ahmed | |
| 245 | 1 | 0 |
_aFormulation and biopharmaceutical evaluation of anti-acne drug in a pharmaceutical form / _cMayada Elhadi Babiker Ahmed ; Supervised Mahmoud Mohamed Ghorab |
| 246 | 1 | 5 | _aدراسة بايوصيدلية على عقار مضاد لحب الشباب |
| 260 |
_aCairo : _bMayada Elhadi Babiker Ahmed , _c2012 |
||
| 300 |
_a134 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aIsotretinoin (13-cis-retinoic acid) is a poor water- soluble drugs commonly used in the treatment of severe cases of acne. The aim of this project is formulate isotretinoin in form of tablet and enhance its solubility and dissolution rate by the use of formulations containing either surfactant (SlS and Tweeen 20) or HP-Ý-CD.The critical micelle concentration for each surfactant was determined | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHP-Ý-CD | |
| 653 | 4 | _aIsotretinoin | |
| 653 | 4 | _aSurfactant enriched tablets | |
| 700 | 0 |
_aMahmoud Mohamed Ghorab , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41790 _d41790 |
||